Theranostic Advances in Breast Cancer in Nuclear Medicine

被引：52
|
作者：
Vahidfar, Nasim [1 ]
Aghanejad, Ayuob [2 ]
Ahmadzadehfar, Hojjat [3 ]
Farzanehfar, Saeed [1 ]
Eppard, Elisabeth [4 ,5 ]
机构：
[1] Univ Tehran Med Sci, Vali Asr Hosp, Dept Nucl Med, Tehran 1419733141, Iran
[2] Tabriz Univ Med Sci, Biomed Inst, Res Ctr Pharmaceut Nanotechnol, Tabriz 51368, Iran
[3] Klinikum Westfalen, Dept Nucl Med, D-44149 Dortmund, Germany
[4] Positronpharma SA, Rancagua 878, Santiago 7500621, Chile
[5] Univ Hosp Magdeburg, Dept Nucl Med, Leipziger Str 44, D-39120 Magdedurg, Germany
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 09期
关键词：
theranostic; radiopharmaceutical; imaging; therapy; GASTRIN-RELEASING-PEPTIDE; NEUROENDOCRINE TUMORS; BOMBESIN RECEPTORS; PET; EXPRESSION; DIAGNOSIS; SUBTYPES; FIBROBLASTS; LIGANDS; PATIENT;
D O I：
10.3390/ijms22094597
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The implication of 'theranostic' refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.
引用
收藏
页数：17
相关论文
共 50 条
  • [41] Theranostic Nanostructures for Ovarian Cancer
    Navyatha, Bankuru
    Nara, Seema
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2019, 36 (04): : 305 - 371
  • [42] Oncological theranostics in nuclear medicine
    Laschinsky, Christina
    Herrmann, Ken
    Fendler, Wolfgang
    Nader, Michael
    Lahner, Harald
    Hadaschik, Boris
    Sandach, Patrick
    RADIOLOGIE, 2022, : 875 - 884
  • [43] Formulation and evaluation of targeted nanoparticles for breast cancer theranostic system
    Dadras, Pegah
    Atyabi, Fatemeh
    Irani, Shiva
    Ma'mani, Leila
    Foroumadi, Alireza
    Mirzaie, Zahra Hadavand
    Ebrahimi, Marzieh
    Dinarvand, R.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 97 : 47 - 54
  • [44] Advances in chemical pharmacotherapy to manage advanced breast cancer
    Gombos, Andrea
    Awada, Ahmad
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (01) : 95 - 103
  • [45] Theranostic Approach in Breast Cancer A Treasured Tailor for Future Oncology
    Jokar, Narges
    Velikyan, Irina
    Ahmadzadehfar, Hojjat
    Rekabpour, Seyed Javad
    Jafari, Esmail
    Ting, Hong Hoi
    Biersack, Hans-Juergen
    Assadi, Majid
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : E410 - E420
  • [46] Theranostic Polymeric Nanoparticles for Cancer
    Fernandes, Donald A.
    BIONANOSCIENCE, 2023, 13 (04) : 1609 - 1644
  • [47] Theranostic Polymeric Nanoparticles for Cancer
    Donald A. Fernandes
    BioNanoScience, 2023, 13 : 1609 - 1644
  • [48] Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review
    Baun, Christina
    Naghavi-Behzad, Mohammad
    Hildebrandt, Malene Grubbe
    Gerke, Oke
    Thisgaard, Helge
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (02) : 256 - 269
  • [49] Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations
    Basirinia, Ghazal
    Ali, Muhammad
    Comelli, Albert
    Sperandeo, Alessandro
    Piana, Sebastiano
    Alongi, Pierpaolo
    Longo, Costanza
    Di Raimondo, Domenico
    Tuttolomondo, Antonino
    Benfante, Viviana
    CANCERS, 2024, 16 (19)
  • [50] Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer
    Hoffman, S. L. V.
    Mixdorf, J. C.
    Kwon, O.
    Johnson, T. R.
    Makvandi, M.
    Lee, H.
    Aluicio-Sarduy, E.
    Barnhart, T. E.
    Jeffery, J. J.
    Patankar, M. S.
    Engle, J. W.
    Bednarz, B. P.
    Ellison, P. A.
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 122
12345